Perrigo InvestorRoom http://perrigo.investorroom.com/ Perrigo Invests In Tarex® Patented Technology, As A Key Investment In The Fight Against Methamphetamine Drug Abuse http://perrigo.investorroom.com/2016-09-27-Perrigo-Invests-In-Tarex-Patented-Technology-As-A-Key-Investment-In-The-Fight-Against-Methamphetamine-Drug-Abuse Tue, 27 Sep 2016 08:16:00 -0400 http://perrigo.investorroom.com/2016-09-27-Perrigo-Invests-In-Tarex-Patented-Technology-As-A-Key-Investment-In-The-Fight-Against-Methamphetamine-Drug-Abuse Perrigo Acknowledges Receipt Of Letter From Starboard Value LP http://perrigo.investorroom.com/2016-09-12-Perrigo-Acknowledges-Receipt-Of-Letter-From-Starboard-Value-LP Mon, 12 Sep 2016 08:12:00 -0400 http://perrigo.investorroom.com/2016-09-12-Perrigo-Acknowledges-Receipt-Of-Letter-From-Starboard-Value-LP Perrigo Company to Present at Upcoming Investor Conferences http://perrigo.investorroom.com/2016-09-07-Perrigo-Company-to-Present-at-Upcoming-Investor-Conferences Wed, 07 Sep 2016 10:07:00 -0400 http://perrigo.investorroom.com/2016-09-07-Perrigo-Company-to-Present-at-Upcoming-Investor-Conferences Perrigo Announces Tentative FDA Approval For Generic Version Of Epiduo® Gel http://perrigo.investorroom.com/2016-09-01-Perrigo-Announces-Tentative-FDA-Approval-For-Generic-Version-Of-Epiduo-Gel Thu, 01 Sep 2016 09:01:00 -0400 http://perrigo.investorroom.com/2016-09-01-Perrigo-Announces-Tentative-FDA-Approval-For-Generic-Version-Of-Epiduo-Gel Perrigo Announces Tentative FDA Approval For Generic Version Of Suprep® Oral Solution And Confirms Patent Challenge For Generic Version Of Mirvaso® Gel http://perrigo.investorroom.com/2016-08-23-Perrigo-Announces-Tentative-FDA-Approval-For-Generic-Version-Of-Suprep-Oral-Solution-And-Confirms-Patent-Challenge-For-Generic-Version-Of-Mirvaso-Gel Tue, 23 Aug 2016 09:10:00 -0400 http://perrigo.investorroom.com/2016-08-23-Perrigo-Announces-Tentative-FDA-Approval-For-Generic-Version-Of-Suprep-Oral-Solution-And-Confirms-Patent-Challenge-For-Generic-Version-Of-Mirvaso-Gel